Valuation: Terumo Corporation

Market Cap 3,794B 23.82B 20.44B 19.17B 17.53B 33.04B 2,272B 33.18B 225B 87.94B 1,148B 89.44B 87.49B P/E 2027 *
19.9x
P/E 2028 * 19.8x
Enterprise Value 3,849B 24.16B 20.74B 19.45B 17.78B 33.51B 2,305B 33.66B 228B 89.21B 1,164B 90.73B 88.75B EV / Sales 2027 *
3.06x
EV / Sales 2028 * 2.83x
Free-Float
97.07%
Yield 2027 *
1.44%
Yield 2028 * 1.58%
1 day-0.94%
1 week+4.05%
Current month+10.67%
1 month+14.36%
3 months+10.17%
6 months+25.62%
Current year+13.30%
1 week 2,526.5
Extreme 2526.5
2,645.5
1 month 2,177.5
Extreme 2177.5
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,708
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%+4.05%-2.80%+19.77% 24.05B
-1.75%+1.26%-13.48%+9.49% 201B
+0.97%-0.08%-0.02%+11.96% 117B
-0.08%+3.69%+13.70%+82.63% 62.6B
-0.12%-1.77%+29.62%+56.62% 52.49B
+0.23%+5.22%-2.28%-32.07% 51.69B
-0.22%-0.71%+17.11%-11.71% 33.65B
-2.97%+1.35% - - 31.27B
+0.41%+0.96%+41.55%-11.13% 24.52B
+0.14%+1.88%-4.71%+4.58% 23.05B
Average -0.43%+1.60%+8.74%+14.46% 62.09B
Weighted average by Cap. -0.56%+1.61%+1.70%+16.46%

Financials

2027 *2028 *
Net sales 1,256B 7.88B 6.77B 6.35B 5.8B 10.94B 752B 10.98B 74.51B 29.11B 380B 29.61B 28.96B 1,336B 8.39B 7.2B 6.75B 6.17B 11.63B 800B 11.68B 79.26B 30.97B 404B 31.5B 30.81B
Net income 189B 1.18B 1.02B 954M 872M 1.64B 113B 1.65B 11.2B 4.37B 57.1B 4.45B 4.35B 191B 1.2B 1.03B 966M 883M 1.66B 114B 1.67B 11.34B 4.43B 57.83B 4.51B 4.41B
Net Debt 54.63B 343M 294M 276M 252M 476M 32.72B 478M 3.24B 1.27B 16.53B 1.29B 1.26B -16.66B -105M -89.79M -84.22M -76.99M -145M -9.98B -146M -989M -386M -5.04B -393M -384M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
26/08/26 JP¥2,572.00 -0.94% 3,286,000
25/08/26 JP¥2,596.50 +0.04% 3,106,200
24/08/26 JP¥2,595.50 +1.03% 3,082,000
21/08/26 JP¥2,569.00 -0.29% 4,562,800
20/08/26 JP¥2,576.50 +4.23% 6,932,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,572.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+21.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock